Olink, part of Thermo Fisher Scientific sponsored Industry Symposium: Advancing Cancer Research Beyond Genomics with Plasma Proteomics

10/06/2026 14:30 15:15
Room F9+10
Proteomics is gaining increasing attention in cancer research by providing functional insights beyond genomics and driving novel biomarker discovery. This symposium highlights how high-throughput proteomics enables a deeper understanding of tumor biology, early detection, and treatment response.
Time Session
14:30
14:32
Introduction
AndreaBallagi Industry Moderator/ Chair Olink, Part of Thermo Fisher ScientificSweden
Room F9+10
14:32
14:46
Multi-modal plasma proteomics for the management of cancer
JanneJanne Lehtiö Industry Speaker Karolinska Institutet and SciLifeLabSweden
Room F9+10
14:46
15:00
Fine needle aspiration coupled with proximity extension assay enables tissue proteomics profiling for precision cancer medicine
BoFranzén Industry Speaker Department of Oncology and PathologySweden
Room F9+10
15:00
15:10
PREDICT Study – Proteomics for Risk Estimation of Developing Immune-Related Complex Toxicity
RobinReschke Industry Speaker Heidelberg University and National Center for Tumor Diseases (NCT)Germany
Room F9+10
15:10
15:15
Q&A
AndreaBallagi Industry Moderator/ Chair Olink, Part of Thermo Fisher ScientificSweden
Room F9+10